Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Revive Therapeutics Ltd > Bucillamine Possible Revenue… Reddit Post - Thx Tradervic4
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by 1ottrunneron Sep 10, 2021 7:55am
129 Views
Post# 33838746

RE:Bucillamine Possible Revenue… Reddit Post - Thx Tradervic4

RE:Bucillamine Possible Revenue… Reddit Post - Thx Tradervic4The drug currently sells for 50 cents per 100mg so this guy starts at twice profits.

RVV is likely going to get somewhere between 5 and 15% of that and will have to cover distribution costs.

If Big Pharma are interested in this they will buy the entire thing including the RVV rights deal.
Shareholders will be lucky to see $1 in that deal.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities